Monday.com (MNDY) Declines More Than Market: Some Information for Investors

Monday.com fell 4.11% to $90.43 in the latest session, underperforming the S&P 500’s 1.09% decline, though the shares gained 4.44% over the past month. Ahead of its upcoming report, consensus calls for quarterly EPS of $1.43 (+23.28% year over year) and revenue of $368.34 million (+16.25%); the 30-day consensus EPS estimate rose 3.85%, while the stock carries a Zacks Rank of #3 (Hold). Its forward P/E of 16.89 is below the industry average of 21.23.

Analysis

The one-day underperformance is weak evidence of a company-specific break: the article gives no company catalyst, and MNDY had recently outperformed. The more relevant signal is the tension between upward EPS revisions and a stock that still sold off. That can reflect a higher bar into earnings, duration-risk pressure on software multiples, or skepticism that EPS growth converts into durable demand—not proof that estimates are wrong. The reported forward-multiple discount is not, by itself, a bargain signal; verify the date, earnings basis, and peer set before using it. Growth-software valuations can compress quickly if billings, retention, or guidance disappoint even while near-term EPS rises.

Over days, broad Nasdaq weakness may dominate idiosyncratic news. Over the next 1–3 months, earnings and forward guidance are the key catalysts: investors need evidence that demand and customer expansion support revenue growth, not just operating leverage. Over 6–18 months, AI-enabled workflow tools could improve product value but also intensify competition and raise customer substitution risk. The contrarian read is that the pullback may be noise after relative outperformance; the counterpoint is that consensus growth is already material, so a modest beat without a stronger outlook may not re-rate the shares. No clear trade before results.

Key Decisions for Investors

• No immediate directional trade on this single-session move. Treat MNDY as an event-risk position and verify the earnings date and current estimate revisions before sizing exposure.
• Post-earnings, consider a staged long only if guidance and demand indicators substantiate continued growth and the EPS revision trend persists; define the thesis as invalidated by a guidance reset or deterioration in reported demand/retention measures.
• If management misses expectations or cuts the outlook, avoid averaging down; consider a short or underweight relative to software peers, with risk capped around the earnings gap and reassessed against subsequent guidance.
• Monitor Nasdaq/software-factor performance separately from company-specific results. A broad sector rebound without estimate support is not confirmation of the fundamental thesis.